Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma.
Mirian C, Grell K, Juratli TA, Sahm F, Spiegl-Kreinecker S, Peyre M, Biczok A, Tonn JC, Goutagny S, Bertero L, Maier AD, Jensen LR, Schackert G, Broholm H, Scheie D, Cahill DP, Brastianos PK, Skjøth-Rasmussen J, Fugleholm K, Ziebell M, Munch TN, Kristensen BW, Mathiesen T. Mirian C, et al. Neuropathol Appl Neurobiol. 2022 Apr;48(3):e12773. doi: 10.1111/nan.12773. Epub 2021 Dec 1. Neuropathol Appl Neurobiol. 2022. PMID: 34799864
Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis.
Mirian C, Duun-Henriksen AK, Juratli T, Sahm F, Spiegl-Kreinecker S, Peyre M, Biczok A, Tonn JC, Goutagny S, Bertero L, Maier AD, Møller Pedersen M, Law I, Broholm H, Cahill DP, Brastianos P, Poulsgaard L, Fugleholm K, Ziebell M, Munch T, Mathiesen T. Mirian C, et al. J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):378-387. doi: 10.1136/jnnp-2019-322257. Epub 2020 Feb 10. J Neurol Neurosurg Psychiatry. 2020. PMID: 32041819 Free article. Review.
TERT promoter mutations in primary and secondary WHO grade III meningioma.
Maier AD, Stenman A, Svahn F, Mirian C, Bartek J Jr, Juhler M, Zedenius J, Broholm H, Mathiesen T. Maier AD, et al. Among authors: mirian c. Brain Pathol. 2021 Jan;31(1):61-69. doi: 10.1111/bpa.12892. Epub 2020 Sep 15. Brain Pathol. 2021. PMID: 32805769 Free PMC article.
Somatostatin Receptor-Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis.
Mirian C, Duun-Henriksen AK, Maier A, Pedersen MM, Jensen LR, Bashir A, Graillon T, Hrachova M, Bota D, van Essen M, Spanjol P, Kreis C, Law I, Broholm H, Poulsgaard L, Fugleholm K, Ziebell M, Munch T, Walter MA, Mathiesen T. Mirian C, et al. J Nucl Med. 2021 Apr;62(4):507-513. doi: 10.2967/jnumed.120.249607. Epub 2020 Aug 28. J Nucl Med. 2021. PMID: 32859705 Free article.
Expression of the stem cell marker CD133 in malignant meningioma.
Maier AD, Mirian C, Bartek J Jr, Juhler M, Bartkova J, Broholm H, Mathiesen TI. Maier AD, et al. Among authors: mirian c. Clin Neuropathol. 2021 May-Jun;40(3):151-159. doi: 10.5414/NP301327. Clin Neuropathol. 2021. PMID: 33250074
Proposal of a new grading system for meningioma resection: the Copenhagen Protocol.
Haslund-Vinding J, Skjoth-Rasmussen J, Poulsgaard L, Fugleholm K, Mirian C, Maier AD, Santarius T, Rom Poulsen F, Meling T, Bartek JJ, Förander P, Larsen VA, Kristensen BW, Scheie D, Law I, Ziebell M, Mathiesen T. Haslund-Vinding J, et al. Among authors: mirian c. Acta Neurochir (Wien). 2022 Jan;164(1):229-238. doi: 10.1007/s00701-021-05025-5. Epub 2021 Oct 29. Acta Neurochir (Wien). 2022. PMID: 34714434
Letter to the Editor. Copenhagen grading of meningioma.
Mathiesen T, Haslund-Vinding J, Skjøth-Rasmussen J, Poulsgaard L, Fugleholm K, Mirian C, Daniela Maier A, Santarius T, Rom Poulsen F, Andrée Larsen V, Winther Kristensen B, Scheie D, Law I, Ziebell M. Mathiesen T, et al. Among authors: mirian c. J Neurosurg. 2022 Jan 21;136(5):1506-1508. doi: 10.3171/2021.10.JNS204467. Print 2022 May 1. J Neurosurg. 2022. PMID: 35061983 No abstract available.
Granular clinical history and outcome in 51 patients with primary and secondary malignant meningioma.
Maier AD, Mirian C, Haslund-Vinding J, Bartek J, Guldager R, Møller S, Munch TN, Fugleholm K, Poulsgaard L, Skjøth-Rasmussen J, Ziebell M, Eriksson LE, Scheie D, Poulsen FR, Mathiesen T. Maier AD, et al. Among authors: mirian c. J Neurosurg. 2022 Mar 11;137(5):1347-1357. doi: 10.3171/2022.1.JNS212723. Print 2022 Nov 1. J Neurosurg. 2022. PMID: 35276654
34 results